View Financial HealthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsFONAR 배당 및 자사주 매입배당 기준 점검 0/6FONAR 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률0.0005%자사주 매입 수익률총 주주 수익률0.0005%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트공고 • Sep 30FONAR Corporation (NasdaqCM:FONR) announces an Equity Buyback for $9 million worth of its shares.FONAR Corporation (NasdaqCM:FONR) announces a share repurchase program. Under the program, the company will repurchase its own shares. The program has no expiration date. On September 26, 2022, the company announced that the Board of Directors has approved up to $9 million to be repurchased under the program.모든 업데이트 보기Recent updates공고 • Jun 03+ 3 more updatesFONAR Corporation(NasdaqCM:FONR) dropped from Russell Microcap IndexFONAR Corporation(NasdaqCM:FONR) dropped from Russell Microcap Index공고 • May 06FONAR Corporation, Annual General Meeting, Jun 17, 2026FONAR Corporation, Annual General Meeting, Jun 17, 2026. Location: at the hilton long island huntington hotel, 598 broadholow road, melvile, new york 11747, United States공고 • Feb 10FONAR Corporation announced delayed 10-Q filingOn 02/09/2026, FONAR Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.New Risk • Dec 31New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 2.1% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Market cap is less than US$100m (€81.8m market cap, or US$96.0m).Buy Or Sell Opportunity • Dec 31Now 23% overvalued after recent price riseOver the last 90 days, the stock has risen 22% to €15.60. The fair value is estimated to be €12.71, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 2.6% over the last 3 years. Earnings per share has declined by 7.2%.공고 • Sep 13FONAR Corporation announced delayed annual 10-K filingOn 09/12/2025, FONAR Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.공고 • Jul 10Timothy Damadian along with management team and Board of Directors of FONAR Corporation and third parties proposed to acquire remaining 94.99% stake in FONAR Corporation (NasdaqCM:FONR).Timothy Damadian along with management team and Board of Directors of FONAR Corporation and third parties proposed to acquire remaining 94.99% stake in FONAR Corporation (NasdaqCM:FONR) on July 7, 2025. The Proposed Acquisition Group currently beneficially owns approximately 5.01% of the outstanding FONAR Stock. The Board of Directors of FONAR Corporation formed a special committee consisting of independent and disinterested directors of the Board, who will carefully review the proposal to determine the course of action that is in the best interests of FONAR Corporation and all shareholders.공고 • Jul 03FONAR Corporation Appoints Robert M. Carrino as an Independent DirectorFONAR Corporation announced that on July 2, 2025, its board of directors appointed Mr. Robert M. Carrino as an independent director of the company’s board of directors. This appointment fills a vacancy on the board left by Ms. Claudette J.V. Chan, who recently retired from her position. Mr. Carrino is a partner at CFGI, LLC in New York City, where he leads the firm’s SPAC practice. He provides complex accounting and consulting services to both public and private companies. Prior to joining CFGI, Mr. Carrino was an audit manager at KPMG, LLP’s Metro New York Long Island Office. Mr. Carrino, a Certified Public Accountant, earned the degree of Bachelor of Science in Business Administration with a concentration in accounting from Western New England University.공고 • Jun 25FONAR Corporation Announces Intention of Claudette J.V. Chan to Retire from the Board of Directors and Secretary, Effective June 19, 2025On June 18, 2025, Claudette J.V. Chan, a member of the Board of Directors and the Secretary of FONAR Corporation, notified the Company of her intention to retire from the Company's Board of Directors, and to retire as Secretary of the Company, effective June 19, 2025. Ms. Chan did not advise the Company of any disagreement with the Company on any matter relating to its operations, policies or practices.공고 • Apr 23FONAR Corporation, Annual General Meeting, May 19, 2025FONAR Corporation, Annual General Meeting, May 19, 2025. Location: hilton long island huntington hotel, 598 broadhollow road, melville, new york 11747, United States공고 • Feb 15FONAR Corporation announced delayed 10-Q filingOn 02/14/2025, FONAR Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.Reported Earnings • Nov 15First quarter 2025 earnings releasedFirst quarter 2025 results: Revenue: US$25.0m (down 3.4% from 1Q 2024). Net income: US$3.14m (down 20% from 1Q 2024). Profit margin: 13% (down from 15% in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 1% per year and the company’s share price has also fallen by 1% per year.New Risk • Oct 13New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €89.7m (US$98.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 3.5% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€89.7m market cap, or US$98.1m).New Risk • Oct 01New major risk - Revenue and earnings growthEarnings have declined by 3.5% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company.Reported Earnings • Sep 29Full year 2024 earnings released: EPS: US$1,637 (vs US$1,425 in FY 2023)Full year 2024 results: EPS: US$1,637 (up from US$1,425 in FY 2023). Revenue: US$102.9b (up 4.3% from FY 2023). Net income: US$10.6b (up 13% from FY 2023). Profit margin: 10% (in line with FY 2023). Over the last 3 years on average, earnings per share has increased by 117% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.공고 • Sep 28FONAR Corporation to Report Fiscal Year 2024 Results on Sep 27, 2024FONAR Corporation announced that they will report fiscal year 2024 results on Sep 27, 2024Reported Earnings • May 17Third quarter 2024 earnings released: EPS: US$0.28 (vs US$0.55 in 3Q 2023)Third quarter 2024 results: EPS: US$0.28 (down from US$0.55 in 3Q 2023). Revenue: US$25.7m (up 1.2% from 3Q 2023). Net income: US$1.87m (down 49% from 3Q 2023). Profit margin: 7.3% (down from 14% in 3Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has fallen by 1% per year.공고 • Apr 09FONAR Corporation, Annual General Meeting, May 20, 2024FONAR Corporation, Annual General Meeting, May 20, 2024, at 10:00 US Eastern Standard Time. Location: The Hilton Long Island Huntington Hotel, 598 Broadhollow Road, Melville New York United States Agenda: To elect five Directors to the Board of Directors; to approve, on an advisory basis, the compensation of the Company’s named executive officers; to recommend, on an advisory basis, whether the advisory stockholder vote to approve the compensation of the Company’s named executive officers be taken every year, every two years, or every three years; to ratify the selection of Marcum LLP as the Company’s auditors for the fiscal year ending June 30, 2024; and to transact such other business as may properly come before the meeting.Reported Earnings • Feb 16Second quarter 2024 earnings released: EPS: US$0.59 (vs US$0.32 in 2Q 2023)Second quarter 2024 results: EPS: US$0.59 (up from US$0.32 in 2Q 2023). Revenue: US$25.4m (up 4.7% from 2Q 2023). Net income: US$3.76m (up 76% from 2Q 2023). Profit margin: 15% (up from 8.8% in 2Q 2023). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 7% per year whereas the company’s share price has increased by 9% per year.Reported Earnings • Nov 16First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: US$25.8m (up 11% from 1Q 2023). Net income: US$4.11m (up 110% from 1Q 2023). Profit margin: 16% (up from 8.4% in 1Q 2023). The increase in margin was driven by higher revenue.Valuation Update With 7 Day Price Move • Nov 16Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €14.90, the stock trades at a trailing P/E ratio of 12x. Average trailing P/E is 30x in the Medical Equipment industry in Germany. Total loss to shareholders of 9.1% over the past three years.New Risk • Oct 03New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €95.3m (US$100.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 17% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€95.3m market cap, or US$100.0m).Reported Earnings • Sep 29Full year 2023 earnings released: EPS: US$1.37 (vs US$1.78 in FY 2022)Full year 2023 results: EPS: US$1.37 (down from US$1.78 in FY 2022). Revenue: US$98.6m (up 1.1% from FY 2022). Net income: US$9.38m (down 21% from FY 2022). Profit margin: 9.5% (down from 12% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.Reported Earnings • May 16Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: US$25.4m (up 3.5% from 3Q 2022). Net income: US$3.69m (up 69% from 3Q 2022). Profit margin: 14% (up from 8.9% in 3Q 2022). The increase in margin was primarily driven by higher revenue.Reported Earnings • Feb 15Second quarter 2023 earnings released: EPS: US$0.34 (vs US$0.57 in 2Q 2022)Second quarter 2023 results: EPS: US$0.34 (down from US$0.57 in 2Q 2022). Revenue: US$24.3m (flat on 2Q 2022). Net income: US$2.23m (down 42% from 2Q 2022). Profit margin: 9.2% (down from 16% in 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 2% per year whereas the company’s share price has fallen by 3% per year.Reported Earnings • Nov 16First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: US$23.2m (down 2.3% from 1Q 2022). Net income: US$2.05m (down 45% from 1Q 2022). Profit margin: 8.8% (down from 16% in 1Q 2022). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 3% per year.Recent Insider Transactions • Oct 05Key Executive recently bought €67k worth of stockOn the 30th of September, Luciano Bonanni bought around 5k shares on-market at roughly €14.34 per share. This transaction amounted to 9.5% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Luciano's only on-market trade for the last 12 months.공고 • Sep 30FONAR Corporation (NasdaqCM:FONR) announces an Equity Buyback for $9 million worth of its shares.FONAR Corporation (NasdaqCM:FONR) announces a share repurchase program. Under the program, the company will repurchase its own shares. The program has no expiration date. On September 26, 2022, the company announced that the Board of Directors has approved up to $9 million to be repurchased under the program.Reported Earnings • Sep 29Full year 2022 earnings released: EPS: US$1.71 (vs US$1.46 in FY 2021)Full year 2022 results: EPS: US$1.71 (up from US$1.46 in FY 2021). Revenue: US$97.6m (up 8.5% from FY 2021). Net income: US$11.9m (up 22% from FY 2021). Profit margin: 12% (up from 11% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 8% per year.공고 • Aug 13FONAR Corporation Announces Passing of Its Chairman of the Board of Directors, Raymond V. DamadianFonar Corporation and it’s board of directors reported the passing of its Chairman of the Board of Directors, Raymond V. Damadian, on August 3, 2022. Highlights of the life of Dr. Raymond Damadian: Founded FONAR Corporation (1978), the first company in the MRI industry, maker of the QED80, the world’s first MRI scanner (1980); Conceived the idea for MRI in 1969; Made the discovery in 1970 that is the basis for the making of every MRI image ever produced, the foundation of the MRI industry. Dr. Damadian discovered that there is a marked difference in the relaxation times of NMR (MRI) signals from normal and cancerous tissues of the same type, as well as from different types of normal tissues. This discovery, published in the peer-reviewed journal ‘Science’ in March 1971 marked the beginning of the MRI industry.; Awarded the world’s first MRI patent (filed in March 1971). This patent was upheld in FONAR’s successful lawsuit against General Electric in 1995.; Built the world’s first MRI scanner, Indomitable, which produced the world’s first MRI scan on July 3, 1977.; Awarded The National Medal of Technology by President Ronald Reagan in 1988.; Inducted into the National Inventors Hall of Fame in 1989, joining a select group of renowned pioneers, including Orville and Wilbur Wright, Henry Ford, Thomas Edison and Alexander Graham Bell. Received the Excellence in Medicine award from the Chiari & Syringomyelia Foundation (CSF) in London England on November 10, 2018.Reported Earnings • May 17Third quarter 2022 earnings released: EPS: US$0.33 (vs US$0.55 in 3Q 2021)Third quarter 2022 results: EPS: US$0.33 (down from US$0.55 in 3Q 2021). Revenue: US$24.6m (up 6.4% from 3Q 2021). Net income: US$2.19m (down 41% from 3Q 2021). Profit margin: 8.9% (down from 16% in 3Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.공고 • Apr 09FONAR Corporation, Annual General Meeting, May 23, 2022FONAR Corporation, Annual General Meeting, May 23, 2022. Location: Double Tree Hotel, Wilmington Downtown, 700 King Street, Wilmington, Delaware 19801 (302-655-0400) New York United States Agenda: To elect five Directors to the Board of Directors; To approve, on an advisory basis, the compensation of the Company’s named executive officers; To ratify the selection of Marcum LLP as the Company’s auditors for the fiscal year ending June 30, 2022; To transact such other business as may properly come before the meeting.Buying Opportunity • Mar 12Now 20% undervaluedOver the last 90 days, the stock is up 17%. The fair value is estimated to be US$19.77, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 27% per annum over the last 3 years.Reported Earnings • Feb 15Second quarter 2022 earnings: Revenues in line with analyst expectationsSecond quarter 2022 results: Revenue: US$24.5m (up 16% from 2Q 2021). Net income: US$3.84m (up 29% from 2Q 2021). Profit margin: 16% (up from 14% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.Reported Earnings • Sep 29Full year 2021 earnings released: EPS US$1.51 (vs US$1.20 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: US$89.9m (up 4.9% from FY 2020). Net income: US$10.2m (up 30% from FY 2020). Profit margin: 11% (up from 9.2% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.공고 • Jun 28+ 8 more updatesFONAR Corporation(NasdaqCM:FONR) dropped from Russell 2000 Defensive IndexFONAR Corporation(NasdaqCM:FONR) dropped from Russell 2000 Defensive IndexReported Earnings • May 15Third quarter 2021 earnings released: EPS US$0.53 (vs US$0.18 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: US$23.1m (up 6.5% from 3Q 2020). Net income: US$3.69m (up 207% from 3Q 2020). Profit margin: 16% (up from 5.6% in 3Q 2020). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.Is New 90 Day High Low • Mar 03New 90-day high: €16.60The company is up 5.0% from its price of €15.80 on 03 December 2020. The German market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is up 16% over the same period.Reported Earnings • Feb 19Second quarter 2021 earnings released: EPS US$0.43 (vs US$0.45 in 2Q 2020)The company reported a soft second quarter result with weaker revenues, although earnings and profit margins were flat. Second quarter 2021 results: Revenue: US$21.2m (down 1.3% from 2Q 2020). Net income: US$2.97m (flat on 2Q 2020). Profit margin: 14% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.Is New 90 Day High Low • Dec 29New 90-day low: €14.00The company is down 25% from its price of €18.60 on 30 September 2020. The German market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is up 10.0% over the same period.공고 • Sep 30FONAR Corporation announced delayed amended 10-K filingOn 09/29/2020, FONAR Corporation announced that they will be unable to file their amended 10-K by the deadline required by the SEC.Reported Earnings • Sep 29Full year earnings released - EPS €1.20Over the last 12 months the company has reported total profits of US$7.86m, down 46% from the prior year. Total revenue was US$85.7m over the last 12 months, down 1.7% from the prior year. Profit margins were 9.2%, which is lower than the 17% margin from last year. The decrease in margin was primarily driven by higher expenses.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 FOAA 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: FOAA 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장FONAR 배당 수익률 vs 시장FOAA의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (FOAA)n/a시장 하위 25% (DE)1.5%시장 상위 25% (DE)4.7%업계 평균 (Medical Equipment)2.6%분석가 예측 (FOAA) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 FOAA 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 FOAA 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 FOAA 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: FOAA 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YDE 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/04 05:38종가2026/06/02 00:00수익2026/03/31연간 수익2025/06/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스FONAR Corporation는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공고 • Sep 30FONAR Corporation (NasdaqCM:FONR) announces an Equity Buyback for $9 million worth of its shares.FONAR Corporation (NasdaqCM:FONR) announces a share repurchase program. Under the program, the company will repurchase its own shares. The program has no expiration date. On September 26, 2022, the company announced that the Board of Directors has approved up to $9 million to be repurchased under the program.
공고 • Jun 03+ 3 more updatesFONAR Corporation(NasdaqCM:FONR) dropped from Russell Microcap IndexFONAR Corporation(NasdaqCM:FONR) dropped from Russell Microcap Index
공고 • May 06FONAR Corporation, Annual General Meeting, Jun 17, 2026FONAR Corporation, Annual General Meeting, Jun 17, 2026. Location: at the hilton long island huntington hotel, 598 broadholow road, melvile, new york 11747, United States
공고 • Feb 10FONAR Corporation announced delayed 10-Q filingOn 02/09/2026, FONAR Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
New Risk • Dec 31New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 2.1% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Market cap is less than US$100m (€81.8m market cap, or US$96.0m).
Buy Or Sell Opportunity • Dec 31Now 23% overvalued after recent price riseOver the last 90 days, the stock has risen 22% to €15.60. The fair value is estimated to be €12.71, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 2.6% over the last 3 years. Earnings per share has declined by 7.2%.
공고 • Sep 13FONAR Corporation announced delayed annual 10-K filingOn 09/12/2025, FONAR Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공고 • Jul 10Timothy Damadian along with management team and Board of Directors of FONAR Corporation and third parties proposed to acquire remaining 94.99% stake in FONAR Corporation (NasdaqCM:FONR).Timothy Damadian along with management team and Board of Directors of FONAR Corporation and third parties proposed to acquire remaining 94.99% stake in FONAR Corporation (NasdaqCM:FONR) on July 7, 2025. The Proposed Acquisition Group currently beneficially owns approximately 5.01% of the outstanding FONAR Stock. The Board of Directors of FONAR Corporation formed a special committee consisting of independent and disinterested directors of the Board, who will carefully review the proposal to determine the course of action that is in the best interests of FONAR Corporation and all shareholders.
공고 • Jul 03FONAR Corporation Appoints Robert M. Carrino as an Independent DirectorFONAR Corporation announced that on July 2, 2025, its board of directors appointed Mr. Robert M. Carrino as an independent director of the company’s board of directors. This appointment fills a vacancy on the board left by Ms. Claudette J.V. Chan, who recently retired from her position. Mr. Carrino is a partner at CFGI, LLC in New York City, where he leads the firm’s SPAC practice. He provides complex accounting and consulting services to both public and private companies. Prior to joining CFGI, Mr. Carrino was an audit manager at KPMG, LLP’s Metro New York Long Island Office. Mr. Carrino, a Certified Public Accountant, earned the degree of Bachelor of Science in Business Administration with a concentration in accounting from Western New England University.
공고 • Jun 25FONAR Corporation Announces Intention of Claudette J.V. Chan to Retire from the Board of Directors and Secretary, Effective June 19, 2025On June 18, 2025, Claudette J.V. Chan, a member of the Board of Directors and the Secretary of FONAR Corporation, notified the Company of her intention to retire from the Company's Board of Directors, and to retire as Secretary of the Company, effective June 19, 2025. Ms. Chan did not advise the Company of any disagreement with the Company on any matter relating to its operations, policies or practices.
공고 • Apr 23FONAR Corporation, Annual General Meeting, May 19, 2025FONAR Corporation, Annual General Meeting, May 19, 2025. Location: hilton long island huntington hotel, 598 broadhollow road, melville, new york 11747, United States
공고 • Feb 15FONAR Corporation announced delayed 10-Q filingOn 02/14/2025, FONAR Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
Reported Earnings • Nov 15First quarter 2025 earnings releasedFirst quarter 2025 results: Revenue: US$25.0m (down 3.4% from 1Q 2024). Net income: US$3.14m (down 20% from 1Q 2024). Profit margin: 13% (down from 15% in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 1% per year and the company’s share price has also fallen by 1% per year.
New Risk • Oct 13New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €89.7m (US$98.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 3.5% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€89.7m market cap, or US$98.1m).
New Risk • Oct 01New major risk - Revenue and earnings growthEarnings have declined by 3.5% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company.
Reported Earnings • Sep 29Full year 2024 earnings released: EPS: US$1,637 (vs US$1,425 in FY 2023)Full year 2024 results: EPS: US$1,637 (up from US$1,425 in FY 2023). Revenue: US$102.9b (up 4.3% from FY 2023). Net income: US$10.6b (up 13% from FY 2023). Profit margin: 10% (in line with FY 2023). Over the last 3 years on average, earnings per share has increased by 117% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.
공고 • Sep 28FONAR Corporation to Report Fiscal Year 2024 Results on Sep 27, 2024FONAR Corporation announced that they will report fiscal year 2024 results on Sep 27, 2024
Reported Earnings • May 17Third quarter 2024 earnings released: EPS: US$0.28 (vs US$0.55 in 3Q 2023)Third quarter 2024 results: EPS: US$0.28 (down from US$0.55 in 3Q 2023). Revenue: US$25.7m (up 1.2% from 3Q 2023). Net income: US$1.87m (down 49% from 3Q 2023). Profit margin: 7.3% (down from 14% in 3Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has fallen by 1% per year.
공고 • Apr 09FONAR Corporation, Annual General Meeting, May 20, 2024FONAR Corporation, Annual General Meeting, May 20, 2024, at 10:00 US Eastern Standard Time. Location: The Hilton Long Island Huntington Hotel, 598 Broadhollow Road, Melville New York United States Agenda: To elect five Directors to the Board of Directors; to approve, on an advisory basis, the compensation of the Company’s named executive officers; to recommend, on an advisory basis, whether the advisory stockholder vote to approve the compensation of the Company’s named executive officers be taken every year, every two years, or every three years; to ratify the selection of Marcum LLP as the Company’s auditors for the fiscal year ending June 30, 2024; and to transact such other business as may properly come before the meeting.
Reported Earnings • Feb 16Second quarter 2024 earnings released: EPS: US$0.59 (vs US$0.32 in 2Q 2023)Second quarter 2024 results: EPS: US$0.59 (up from US$0.32 in 2Q 2023). Revenue: US$25.4m (up 4.7% from 2Q 2023). Net income: US$3.76m (up 76% from 2Q 2023). Profit margin: 15% (up from 8.8% in 2Q 2023). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 7% per year whereas the company’s share price has increased by 9% per year.
Reported Earnings • Nov 16First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: US$25.8m (up 11% from 1Q 2023). Net income: US$4.11m (up 110% from 1Q 2023). Profit margin: 16% (up from 8.4% in 1Q 2023). The increase in margin was driven by higher revenue.
Valuation Update With 7 Day Price Move • Nov 16Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €14.90, the stock trades at a trailing P/E ratio of 12x. Average trailing P/E is 30x in the Medical Equipment industry in Germany. Total loss to shareholders of 9.1% over the past three years.
New Risk • Oct 03New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €95.3m (US$100.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 17% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€95.3m market cap, or US$100.0m).
Reported Earnings • Sep 29Full year 2023 earnings released: EPS: US$1.37 (vs US$1.78 in FY 2022)Full year 2023 results: EPS: US$1.37 (down from US$1.78 in FY 2022). Revenue: US$98.6m (up 1.1% from FY 2022). Net income: US$9.38m (down 21% from FY 2022). Profit margin: 9.5% (down from 12% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.
Reported Earnings • May 16Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: US$25.4m (up 3.5% from 3Q 2022). Net income: US$3.69m (up 69% from 3Q 2022). Profit margin: 14% (up from 8.9% in 3Q 2022). The increase in margin was primarily driven by higher revenue.
Reported Earnings • Feb 15Second quarter 2023 earnings released: EPS: US$0.34 (vs US$0.57 in 2Q 2022)Second quarter 2023 results: EPS: US$0.34 (down from US$0.57 in 2Q 2022). Revenue: US$24.3m (flat on 2Q 2022). Net income: US$2.23m (down 42% from 2Q 2022). Profit margin: 9.2% (down from 16% in 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 2% per year whereas the company’s share price has fallen by 3% per year.
Reported Earnings • Nov 16First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: US$23.2m (down 2.3% from 1Q 2022). Net income: US$2.05m (down 45% from 1Q 2022). Profit margin: 8.8% (down from 16% in 1Q 2022). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 3% per year.
Recent Insider Transactions • Oct 05Key Executive recently bought €67k worth of stockOn the 30th of September, Luciano Bonanni bought around 5k shares on-market at roughly €14.34 per share. This transaction amounted to 9.5% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Luciano's only on-market trade for the last 12 months.
공고 • Sep 30FONAR Corporation (NasdaqCM:FONR) announces an Equity Buyback for $9 million worth of its shares.FONAR Corporation (NasdaqCM:FONR) announces a share repurchase program. Under the program, the company will repurchase its own shares. The program has no expiration date. On September 26, 2022, the company announced that the Board of Directors has approved up to $9 million to be repurchased under the program.
Reported Earnings • Sep 29Full year 2022 earnings released: EPS: US$1.71 (vs US$1.46 in FY 2021)Full year 2022 results: EPS: US$1.71 (up from US$1.46 in FY 2021). Revenue: US$97.6m (up 8.5% from FY 2021). Net income: US$11.9m (up 22% from FY 2021). Profit margin: 12% (up from 11% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 8% per year.
공고 • Aug 13FONAR Corporation Announces Passing of Its Chairman of the Board of Directors, Raymond V. DamadianFonar Corporation and it’s board of directors reported the passing of its Chairman of the Board of Directors, Raymond V. Damadian, on August 3, 2022. Highlights of the life of Dr. Raymond Damadian: Founded FONAR Corporation (1978), the first company in the MRI industry, maker of the QED80, the world’s first MRI scanner (1980); Conceived the idea for MRI in 1969; Made the discovery in 1970 that is the basis for the making of every MRI image ever produced, the foundation of the MRI industry. Dr. Damadian discovered that there is a marked difference in the relaxation times of NMR (MRI) signals from normal and cancerous tissues of the same type, as well as from different types of normal tissues. This discovery, published in the peer-reviewed journal ‘Science’ in March 1971 marked the beginning of the MRI industry.; Awarded the world’s first MRI patent (filed in March 1971). This patent was upheld in FONAR’s successful lawsuit against General Electric in 1995.; Built the world’s first MRI scanner, Indomitable, which produced the world’s first MRI scan on July 3, 1977.; Awarded The National Medal of Technology by President Ronald Reagan in 1988.; Inducted into the National Inventors Hall of Fame in 1989, joining a select group of renowned pioneers, including Orville and Wilbur Wright, Henry Ford, Thomas Edison and Alexander Graham Bell. Received the Excellence in Medicine award from the Chiari & Syringomyelia Foundation (CSF) in London England on November 10, 2018.
Reported Earnings • May 17Third quarter 2022 earnings released: EPS: US$0.33 (vs US$0.55 in 3Q 2021)Third quarter 2022 results: EPS: US$0.33 (down from US$0.55 in 3Q 2021). Revenue: US$24.6m (up 6.4% from 3Q 2021). Net income: US$2.19m (down 41% from 3Q 2021). Profit margin: 8.9% (down from 16% in 3Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.
공고 • Apr 09FONAR Corporation, Annual General Meeting, May 23, 2022FONAR Corporation, Annual General Meeting, May 23, 2022. Location: Double Tree Hotel, Wilmington Downtown, 700 King Street, Wilmington, Delaware 19801 (302-655-0400) New York United States Agenda: To elect five Directors to the Board of Directors; To approve, on an advisory basis, the compensation of the Company’s named executive officers; To ratify the selection of Marcum LLP as the Company’s auditors for the fiscal year ending June 30, 2022; To transact such other business as may properly come before the meeting.
Buying Opportunity • Mar 12Now 20% undervaluedOver the last 90 days, the stock is up 17%. The fair value is estimated to be US$19.77, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 27% per annum over the last 3 years.
Reported Earnings • Feb 15Second quarter 2022 earnings: Revenues in line with analyst expectationsSecond quarter 2022 results: Revenue: US$24.5m (up 16% from 2Q 2021). Net income: US$3.84m (up 29% from 2Q 2021). Profit margin: 16% (up from 14% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
Reported Earnings • Sep 29Full year 2021 earnings released: EPS US$1.51 (vs US$1.20 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: US$89.9m (up 4.9% from FY 2020). Net income: US$10.2m (up 30% from FY 2020). Profit margin: 11% (up from 9.2% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.
공고 • Jun 28+ 8 more updatesFONAR Corporation(NasdaqCM:FONR) dropped from Russell 2000 Defensive IndexFONAR Corporation(NasdaqCM:FONR) dropped from Russell 2000 Defensive Index
Reported Earnings • May 15Third quarter 2021 earnings released: EPS US$0.53 (vs US$0.18 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: US$23.1m (up 6.5% from 3Q 2020). Net income: US$3.69m (up 207% from 3Q 2020). Profit margin: 16% (up from 5.6% in 3Q 2020). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.
Is New 90 Day High Low • Mar 03New 90-day high: €16.60The company is up 5.0% from its price of €15.80 on 03 December 2020. The German market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is up 16% over the same period.
Reported Earnings • Feb 19Second quarter 2021 earnings released: EPS US$0.43 (vs US$0.45 in 2Q 2020)The company reported a soft second quarter result with weaker revenues, although earnings and profit margins were flat. Second quarter 2021 results: Revenue: US$21.2m (down 1.3% from 2Q 2020). Net income: US$2.97m (flat on 2Q 2020). Profit margin: 14% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
Is New 90 Day High Low • Dec 29New 90-day low: €14.00The company is down 25% from its price of €18.60 on 30 September 2020. The German market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is up 10.0% over the same period.
공고 • Sep 30FONAR Corporation announced delayed amended 10-K filingOn 09/29/2020, FONAR Corporation announced that they will be unable to file their amended 10-K by the deadline required by the SEC.
Reported Earnings • Sep 29Full year earnings released - EPS €1.20Over the last 12 months the company has reported total profits of US$7.86m, down 46% from the prior year. Total revenue was US$85.7m over the last 12 months, down 1.7% from the prior year. Profit margins were 9.2%, which is lower than the 17% margin from last year. The decrease in margin was primarily driven by higher expenses.